Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
105
天
From Recommendation to Implementation: Clinical Outcomes of a Single-Center Molecular Tumor Board
作者
Tabea Fröhlich; Ulrich Lehmann; Tanja Reineke-Plaaß; Thomas Wirth; Sabrina Welland; Chen Du; Bernd Auber; Benjamin-Alexander Bollmann; Philipp Ivanyi; Tjoung-Won Park-Simon; Diana Steinmann; Christian Hartmann; Ariana de Oliviera Mekonnen; Anja Heutling; Andrea Schütte; Hans Heinrich Wedemeyer; Florian Heinrich Heidel; Susanne Isfort; Arndt Vogel; Anna Saborowski展开收起
作者单位
1. Center for Personalized Medicine (Zentrum für Personalisierte Medizin, ZPM), Comprehensive Cancer Center (CCC) Hannover (Claudia von Schilling Center), Hannover Medical School, Hannover, Germany; 2. Department of Hematology, Hemostasis, Oncology and Cell Therapy, Hannover Medical School, Hannover, Germany; 3. PRACTIS Clinician Scientist Program, Dean’s Office for Academic Career Development, Hannover Medical School, Hannover, Germany; 4. Institute of Pathology, Hannover Medical School, Hannover, Germany; 5. Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany; 6. Institute of Human Genetics, Hannover Medical School, Hannover, Germany; 7. Department of Pneumology and Infectious Diseases, Hannover Medical School, Hannover, Germany; 8. Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany; 9. Department of Radiation Oncology and Special Oncology, Hannover Medical School, Hannover, Germany; 10. Department of Neuropathology, Institute of Pathology, Hannover Medical School, Hannover, Germany; 11. Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany; 12. Division of Gastroenterology and Hepatology, Toronto General Hospital, Medical Oncology, Princess Margaret Cancer Centre, Schwartz Reisman Liver Research Centre, Toronto, Canada展开收起
39
天
Real-World Treatment Patterns in Advanced Cutaneous Melanoma in the USA
作者
Matthew S. Block; Ashley E. Stenzel; Rene Marcotte; Katrine L. Wallace展开收起
作者单位
1. Mayo Clinic, Comprehensive Cancer Center, Rochester, USA; 2. Replimune Inc, Woburn, USA; 3. RCM Consulting, Attleboro, USA; 4. University of Illinois Chicago, School of Public Health, Chicago, USA展开收起
134
天
Efficacy and Safety Differences Between Abiraterone and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis of Real-World Studies
作者
Anikó Katalin Valikovics; Dániel Bacsó; Nadeen Samaien; Isabel Pinto Amorim das Virgens; Boglárka Szentes; Gergely Agócs; Mahmoud Obeidat; Tamás Széll; Boris Hadaschik; Péter Hegyi; Péter Nyirády; Tibor Szarvas展开收起
作者单位
1. Centre for Translational Medicine, Semmelweis University, Budapest, Hungary; 2. Department of Urology, Semmelweis University, Budapest, Hungary; 3. Department of Urology, University of Duisburg-Essen and German Cancer Consortium, Essen, Germany; 4. Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary; 5. Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary展开收起
74
天
Chimeric Antigen Receptor-T Cell Therapy for Pediatric and Young Adult Primary Central Nervous System Tumors: A Systematic Review of Early Phase Clinical Trials with a Focus on Diffuse Midline Glioma
作者
Sai Sanikommu; Alejandro N. Santos; Bashar Dawoud; Khushi H. Shah; Sima Vazquez; Ashish H. Shah; Victor M. Lu展开收起
作者单位
1. Department of Neurosurgery, Miller School of Medicine, University of Miami, Miami, USA展开收起
70
天
Afatinib Versus Osimertinib as First-Line Treatment for Advanced EGFR -Mutant Non-Small-Cell Lung Cancer: A 3-Year Follow-Up Overall Survival Analysis
作者
Yen-Hsiang Huang; Kuo-Hsuan Hsu; Jeng-Sen Tseng; Po-Hsin Lee; I-Hung Lin; Mu-Han Peng; Tsung-Ying Yang展开收起
作者单位
1. Department of Chest Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; 2. Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital, Taichung, Taiwan; 3. School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; 4. Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan; 5. Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan; 6. Doctoral Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan; 7. Rong Hsing Translational Medicine Research Center, National Chung Hsing University, Taichung, Taiwan展开收起
76
天
Real-World Outcomes of Adjuvant Pembrolizumab for Renal Cell Carcinoma: The Potential Role of PD-L1 as a Prognostic Biomarker
作者
Hiroki Ishihara; Takayuki Nakayama; Hironori Fukuda; Nanaka Katsurayama; Yuki Nemoto; Shinsuke Mizoguchi; Hiroaki Shimmura; Yasunobu Hashimoto; Atsuko Seki; Kazuhiko Yoshida; Junpei Iizuka; Tsunenori Kondo; Yoji Nagashima; Toshio Takagi展开收起
作者单位
1. Department of Urology, Saiseikai Kawaguchi General Hospital, Kawaguchi, Japan; 2. Department of Urology, Tokyo Women’s Medical University, Tokyo, Japan; 3. Department of Urology, Tokyo Women’s Medical University Adachi Medical Center, Tokyo, Japan; 4. Department of Urology, Jyoban Hospital, Iwaki, Japan; 5. Department of Urology, Saiseikai Kazo Hospital, Kazo, Japan展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天